[老年人心肌梗塞:在FIRE试验之后,对所有人进行完整的冠状动脉再血管化 ?]
Gabriel Chevrot1, Giorgia Piccagliani1, Marie Hauguel-Moreau1
1Service de cardiologie, Hôpital Ambroise Paré, Assistance Publique-Hôpitaux de Paris (AP-HP), Boulogne-Billancourt, Université de Versailles-Saint Quentin (UVSQ), INSERM U1018, CESP, Villejuif, ACTION Study group, Paris, France.
Annales de cardiologie et d'angeiologie
|August 9, 2025
概括
由冠状动脉生理学指导的完整复血管化有利于75岁以上的多血管冠状动脉疾病的老年患者. 个性化治疗至关重要,特别是对于脆弱的患者,考虑到并发症和偏好.
科学领域:
- 心脏病学 心脏病学
- 老年医学 老年医学
- 干预心脏病学 干预心脏病学
背景情况:
- 心肌梗塞 (MI) 是全球主要的死亡原因,不成比例地影响老年人.
- 对患有多血管冠状动脉疾病 (CAD) 的老年患者的治疗研究不足.
- 老年患者面临更高的术后并发症风险.
研究的目的:
- 以冠状动脉生理学为指导,对患有多血管冠状动脉病的老年患者进行完全重血管化的疗效和安全性进行评估.
- 为了比较生理指导与特定老年人亚组中其他策略的结果.
- 在老年人中为MI管理提供临床决策的信息.
主要方法:
- 审查最近的研究,包括火 (2023),花-MI,和高级-RITA (2024).
- 基于分量流量储备 (FFR) 或定量流量比率 (QFR) 引导的完整再血管化的数据分析.
- 基于生理状态和并发症的老年患者结局的比较.
主要成果:
- FIRE研究表明,完全的生理指导的重血管化可以在75岁以上的患者中减少心血管事件,而不会增加并发症.
- 在年轻患者中,FLOWER-MI发现FFR指导没有益处.
- SENIOR-RITA表示,侵入性策略并没有改善非ST升高ACS后非常并发症的老年患者的存活率,但减少了复发性MIs.
结论:
- 完整的生理指导重血管化对强壮或轻度并发症的老年患者是有益的和安全的.
- 对于脆弱的老年人来说,保守的方法可能是最好的.
- 个性化治疗决策,考虑到脆弱性和患者偏好,是必不可少的,理想情况下与心脏病老年团队的输入.
相关概念视频
01:30Acute Coronary Syndrome III: Diagnostic Studies
23
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
23
01:28Acute Coronary Syndrome IV: Interprofessional Care
27
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
27
01:17Ischemic Heart Disease: Overview
1.4K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.4K
01:27Coronary Artery Disease V: Interprofessional Care
30
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
30
01:30Acute Coronary Syndrome I: Introduction
72
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
72
01:30Coronary Artery Disease III: Clinical Manifestations
34
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
34